Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction".
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nilanjana Maulik |
| Publication date | January 6, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |